Philomène Lavis

409 citations
9 papers · 253 indexed · h-index 6
Topics
Peptidase Inhibition and Analysis (3 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers)COVID-19 Clinical Research Studies (2 papers)
Partner nations
BelgiumNetherlands

In The Last Decade

Philomène Lavis

8 papers receiving 245 citations

Peers

Philomène Lavis
Comparison fields: 5 of 59
  • Infectious Diseases 168
  • Neurology 102
  • Oncology 51
  • Pulmonary and Respiratory Medicine 38
  • Epidemiology 31
Replace Vika Damay with:
Vika Damay Indonesia
Houssam Bkiyar Morocco
Kulachanya Suwanwongse United States
Emmanuelle Sacco France
Muxin Zhu China
Brian Ngure Kenya
Eunice Ka Hong Leung Hong Kong
Quan Cao China
Eva M. Hoekstra Netherlands
Haleh Mikaeili Iran
Philomène Lavis relative to Vika Damay Indonesia Vika Damay's profile →
Citations per field
00.5×
Vika Damay · 1×
Citations per year

Countries citing papers authored by Philomène Lavis

Since Specialization
Citations

This map shows the geographic impact of Philomène Lavis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philomène Lavis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philomène Lavis more than expected).

Fields of papers citing papers by Philomène Lavis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philomène Lavis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philomène Lavis. The network helps show where Philomène Lavis may publish in the future.

Co-authorship network of co-authors of Philomène Lavis

This figure shows the co-authorship network connecting the top 25 collaborators of Philomène Lavis. A scholar is included among the top collaborators of Philomène Lavis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philomène Lavis. Philomène Lavis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 3
2 1
3 5
4 9
5 0
6 15
7 14
8 15
9 191

About Philomène Lavis

Philomène Lavis is a scholar working on Oncology, Infectious Diseases and Immunology, having authored 9 papers that have together received 253 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (168 citations), Neurology (102 citations) and Critical Care and Intensive Care Medicine (20 citations). Philomène Lavis has collaborated with scholars based in Belgium and Netherlands. Frequent co-authors include Isabelle Salmon, Myriam Remmelink, Christine Decaestecker, Lorenzo Peluso, Jean‐Louis Vincent, Fabio Silvio Taccone, Nicky D’Haene, Laetitia Lebrun, Marie-Lucie Racu and Calliope Maris. Their work appears in journals such as Frontiers in Immunology, Critical Care and Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026